Dose response to chlorthalidone in patients with mild hypertension. Efficacy of a lower dose

Clinical Pharmacology and Therapeutics
B J MatersonJ H Morledge

Abstract

A multicenter study of chlorthalidone was performed to determine the relative antihypertensive efficacy and side effects of doses lower than those usually recommended for therapy. After a 4-wk placebo control period 100 patients with mild hypertension were randomly assigned doubleblind to 12.5-, 25-, 50-, or 75-mg regimens of chlorthalidone or to placebo for 12 wk. The groups of patients taking 25, 50, and 75 mg had declines in blood pressure which were not significantly different from each other. Serum potassium decreased in the 50- and 75-mg groups but not significantly in the 25-mg group. We conclude that chlorthalidone, 25 mg daily, was at least as effective for hypertension as 50 and 75 mg with less perturbation of potassium. Use of smaller initial diuretic doses may provide equal efficacy with fewer side effects for many patients.

Citations

Jan 1, 1991·European Journal of Clinical Pharmacology·R Vander Stichele
Aug 1, 1982·British Journal of Clinical Pharmacology·P R WilkinsonE B Raftery
Jan 1, 1981·European Journal of Clinical Pharmacology·J G RussellI S Humphries
Jan 1, 1981·European Journal of Clinical Pharmacology·J C RoosE J Dorhout Mees
Dec 17, 2009·Cardiology in Review·Kimberly M Neff, James J Nawarskas
Jul 11, 2013·Current Hypertension Reports·George C RoushTheodore R Holford
Jan 1, 1989·Irish Journal of Medical Science·G D Johnston
Nov 1, 1986·Journal of Clinical Pharmacology·D E Hutcheon, J C Martinez
Jan 1, 1987·European Journal of Clinical Pharmacology·A SalvettiL Papi
Jan 1, 1984·Acta Pharmacologica Et Toxicologica·C Bengtsson
May 1, 1994·Journal of Internal Medicine·C D FurbergB M Psaty
Mar 28, 2006·Journal of the American Society of Nephrology : JASN·Antonio Salvetti, Lorenzo Ghiadoni
May 28, 2008·Hypertension·Barry L CarterUNKNOWN Working Group from the National Heart, Lung, and Blood Institute
Aug 12, 2009·Expert Opinion on Pharmacotherapy·Domenic A Sica
May 30, 2014·The Cochrane Database of Systematic Reviews·Vijaya M MusiniJames M Wright
Jan 22, 2014·Expert Opinion on Pharmacotherapy·Juan TamargoLuis M Ruilope
Jun 1, 1984·Journal of Medical Systems·P L Miller, H R Black
Mar 1, 1986·Journal of the American Geriatrics Society·J H MorledgeM Davidov
Jan 1, 1982·European Journal of Clinical Pharmacology·J T Salonen, R Palminteri
Jun 1, 1986·Hypertension·P F Magee, E D Freis
Sep 1, 1985·Drug Intelligence & Clinical Pharmacy·J M McKenney
Apr 27, 2012·The Journal of Clinical Hypertension·Barry L Carter
Feb 1, 1984·Computers and Biomedical Research, an International Journal·P L Miller, H R Black
May 1, 1989·Hypertension·R W Gifford, R A Borazanian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.